For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Post COVID-19 Hypoxemic Respiratory Failure Residual Pathophysiologic Outcomes

Clinical Trial Details

The purpose of this study is to learn about the natural history of COVID-19 and its causes and see what effects it has on your lungs.

All participants will be in the study for about 1 year. Each participant will have 4 or 5 visits.

This study includes the following at every visit:

  •     Lung Imaging; CT scans of the Chest
  •     Breathing Tests; Pulmonary Function Tests
  •     Questionnaires
  •     Blood Samples
  •     Exercise Test; 6 Minute Walk Test
  •     Physicial Exams 

All participants will be compensated $150 for each completed visit.

Key Eligibility: 

 Individuals who:

  •     Are at least 18 years old
  •     Have been recently hospitalized or diagnosed with COVID-19 by a health care professional
  •     Required treatment with supplemental oxygen during and/or following the diagnosis of COVID-19 

Eligibility will be discussed with the study team.

Study contact by location

Upper East Side - Manhattan

Contact(s)

Alicia Morris
646-962-2741
pulmonaryresearch@med.cornell.edu

Keyla Ordonez
646-962-2740

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

2005022161

Status

Open to Enrollment

Age Group

Adult

Sponsor

Disease